Skip to main content

First Bellwether Trial Over Hernia Mesh To Begin This Week

First Bellwether Trial Over Hernia Mesh To Begin This Week

First Bellwether Trial Over Hernia Mesh To Begin This Week

Introduction

The trial of the first bellwether case against C.R. Bard will begin this week, where the juries will discover testimonies and evidence in the thousands of hernia mesh lawsuits with allegations of defective designs.

The trial will include videotape testimony from expert witnesses and two dozen facts. It is expected to last for five weeks and two days.

The plaintiff of the trial alleges C.R. Bard's Ventralight ST mesh device caused injuries. The device failed to serve the purpose and caused uneasiness for the plaintiff. The plaintiff even alleged that the manufacturer did not provide adequate warnings about the device. The defendant even failed to provide an accurate way to use the device. Other allegations include that the defendant did not conduct sufficient research and testing before distributing the products.

Bard even requested the federal judge to exclude the testimony of an FDA expert, but the judge rejected the manufacturer's plea. The second bellwether trial against the manufacturer is set to begin on January 10, 2022.

Currently, Bard faces over 8,000 product liability lawsuits from individuals who allege that they experienced complications after a hernia repair. Bard Ventralex, Bard Ventralight, Bard Perfix, Bard 3DMax, and other mesh systems are the products that are alleged of having defective designs.

The plaintiffs allege the products involve a polypropylene mesh design that is dangerous and defective. The product is required to be removed or replaced by a new one after a few years as it wears down.

U.S. District Judge Edmund A. Sargus, Jr. is overseeing the MDL in the Southern District of Ohio for a common outcome of all the lawsuits.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!